$BGXX
Bright Green Corp Stock $bgxx

$bgxx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224020671 Filed on May 20, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.734M	$2.455M
YoY Change	-29.38%	359.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$144.0K	$157.5K
YoY Change	-8.58%	-17.87%
% of Gross Profit
Operating Expenses	$1.878M	$2.613M
YoY Change	-28.12%	259.69%
Operating Profit	-$1.878M	-$2.613M
YoY Change	-28.12%	259.69%
Interest Expense	$15.00K	-$640.00
YoY Change	-2443.75%
% of Operating Profit
Other Income/Expense, Net	$928.4K	$642.00
YoY Change	144513.24%
Pretax Income	-$949.5K	-$2.613M
YoY Change	-63.67%	259.78%
Income Tax
% Of Pretax Income
Net Earnings	-$949.5K	-$2.613M
YoY Change	-63.67%	259.78%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	-$0.02
Diluted Earnings Per Share	-$0.01	-$0.02
COMMON SHARES
Basic Shares Outstanding	187.5M shares	173.4M shares
Diluted Shares Outstanding	187.5M shares	173.4M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$422.5K
YoY Change	-100.0%	-34.82%
Cash & Equivalents		$422.5K
Short-Term Investments
Other Short-Term Assets	$55.52K	$70.08K
YoY Change	-20.78%	-41.87%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$55.52K	$492.6K
YoY Change	-88.73%	-35.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.89M	$18.57M
YoY Change	-14.43%	133.37%
Goodwill
YoY Change
Intangibles	$6.450K	$1.000K
YoY Change	545.0%
Long-Term Investments	$0.00	$3.991M
YoY Change	-100.0%
Other Assets		$1.110M
YoY Change
Total Long-Term Assets	$15.90M	$23.68M
YoY Change	-32.84%	197.43%
TOTAL ASSETS
Total Short-Term Assets	$55.52K	$492.6K
Total Long-Term Assets	$15.90M	$23.68M
Total Assets	$15.96M	$24.17M
YoY Change	-33.98%	176.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.490M	$6.361M
YoY Change	-29.42%	759.65%
Accrued Expenses	$21.94K	$938.4K
YoY Change	-97.66%	1676.85%
Deferred Revenue
YoY Change
Short-Term Debt	$165.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.677M	$8.949M
YoY Change	-47.74%	655.25%
LONG-TERM LIABILITIES
Long-Term Debt	$166.2K	$3.460M
YoY Change	-95.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$166.2K	$3.460M
YoY Change	-95.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.677M	$8.949M
Total Long-Term Liabilities	$166.2K	$3.460M
Total Liabilities	$4.843M	$12.41M
YoY Change	-60.97%	947.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.15M	-$36.69M
YoY Change	31.25%
Common Stock	$59.27M	$48.45M
YoY Change	22.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.11M	$11.76M
YoY Change
Total Liabilities & Shareholders Equity	$15.96M	$24.17M
YoY Change	-33.98%	176.88%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$949.5K	-$2.613M
YoY Change	-63.67%	259.78%
Depreciation, Depletion And Amortization	$144.0K	$157.5K
YoY Change	-8.58%	-17.87%
Cash From Operating Activities	-$58.55K	$273.4K
YoY Change	-121.42%	98.28%
INVESTING ACTIVITIES
Capital Expenditures	$56.06K	$1.586M
YoY Change	-96.46%	-292.83%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$47.94K
YoY Change	-100.0%
Cash From Investing Activities	-$61.51K	-$1.538M
YoY Change	-96.0%	87.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$880.0K
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$110.0K	$1.272M
YoY Change	-91.35%	2444.41%
NET CHANGE
Cash From Operating Activities	-$58.55K	$273.4K
Cash From Investing Activities	-$61.51K	-$1.538M
Cash From Financing Activities	$110.0K	$1.272M
Net Change In Cash	-$10.06K	$7.928K
YoY Change	-226.88%	-101.25%
FREE CASH FLOW
Cash From Operating Activities	-$58.55K	$273.4K
Capital Expenditures	$56.06K	$1.586M
Free Cash Flow	-$114.6K	-$1.312M
YoY Change	-91.27%	-236.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Cash Cash		usd
CY2024Q1	BGXX	Due To Others Current DueToOthersCurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q1	BGXX	Change In Fair Value Of Assets And Liabilities Net ChangeInFairValueOfAssetsAndLiabilitiesNet		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	BGXX	Change In Fair Value Of Assets And Liabilities Net ChangeInFairValueOfAssetsAndLiabilitiesNet		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	BGXX	Transfer From Due To Related Party To Related Party Loc TransferFromDueToRelatedPartyToRelatedPartyLOC		usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	BGXX	Related Party Payroll Liability In Exchange For Common Stock RelatedPartyPayrollLiabilityInExchangeForCommonStock		usd
CY2023Q1	BGXX	Adjustment To Prepaid Expenses And Other Assets For Forfeited Deposit In Settlement Of Debt AdjustmentToPrepaidExpensesAndOtherAssetsForForfeitedDepositInSettlementOfDebt		usd
CY2023Q1	BGXX	Adjustment To Construction In Progress For Return Of Equipment In Settlement Of Debt AdjustmentToConstructionInProgressForReturnOfEquipmentInSettlementOfDebt		usd
CY2023Q1	BGXX	Adjustment To Other Investment Held At Fair Value For Return Of Shares In Settlement Of Debt AdjustmentToOtherInvestmentHeldAtFairValueForReturnOfSharesInSettlementOfDebt		usd
CY2023Q1	BGXX	Settlement Of Accounts Payable In Exchange For Other Investment Held At Fair Value SettlementOfAccountsPayableInExchangeForOtherInvestmentHeldAtFairValue		usd
CY2023Q1	BGXX	Settlement Of Due To Others In Exchange For Other Investment Held At Fair Value SettlementOfDueToOthersInExchangeForOtherInvestmentHeldAtFairValue		usd
CY2024Q1	us-gaap	Investments Investments		usd
CY2024Q1	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit		usd
CY2024Q1	us-gaap	Other Investment Not Readily Marketable Fair Value OtherInvestmentNotReadilyMarketableFairValue		usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	BGXX	Due To Others Current DueToOthersCurrent	1650000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4676545	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6236319	usd
CY2024Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	166235	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	201783	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	166235	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	201783	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4842780	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6438102	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190166318	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190166318	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184758818	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184758818	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	19017	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	18476	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	59247455	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	58149938	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48152919	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47203469	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11113553	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10964945	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15956333	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17403047	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1733839	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2455082	usd
CY2024Q1	us-gaap	Depreciation Depreciation	144028	usd
CY2023Q1	us-gaap	Depreciation Depreciation	157541	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1877867	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2612623	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1877867	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2612623	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	533	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-642	usd
CY2024Q1	BGXX	Change In Fair Value Of Assets And Liabilities Net ChangeInFairValueOfAssetsAndLiabilitiesNet	80705	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1008589	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	928417	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-642	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-949450	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2613265	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-949450	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187511977	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187511977	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	173445814	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	173445814	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10964945	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	130318	usd
CY2024Q1	BGXX	Stock Issued During Period Value Common Stock Issued For Settlement Of Accounts Payable StockIssuedDuringPeriodValueCommonStockIssuedForSettlementOfAccountsPayable	425920	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	541820	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11113553	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2023Q1	BGXX	Stock Issued During Period Value Warrants Exercised For Cash StockIssuedDuringPeriodValueWarrantsExercisedForCash	210000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	880000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	880000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	823900	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11759471	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11759471	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-949450	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	533	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-642	usd
CY2024Q1	BGXX	Change In Fair Value Of Assets And Liabilities Net ChangeInFairValueOfAssetsAndLiabilitiesNet	80705	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1008589	usd
CY2024Q1	us-gaap	Depreciation Depreciation	144028	usd
CY2023Q1	us-gaap	Depreciation Depreciation	157541	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	672138	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	823900	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-63088	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7767	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	883845	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1326189	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	36764	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	491031	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	19452	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	79586	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-58552	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	273391	usd
CY2023Q1	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits	-47944	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5450	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56057	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1585612	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61507	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1537668	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	110000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	150000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	17795	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	150000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	880000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	210000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	110000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1272205	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10059	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7928	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10059	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	414574	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	422502	usd
CY2023Q1	BGXX	Transfer From Due To Related Party To Related Party Loc TransferFromDueToRelatedPartyToRelatedPartyLOC	392194	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	880000	usd
CY2024Q1	BGXX	Related Party Payroll Liability In Exchange For Common Stock RelatedPartyPayrollLiabilityInExchangeForCommonStock	-425920	usd
CY2024Q1	BGXX	Adjustment To Prepaid Expenses And Other Assets For Forfeited Deposit In Settlement Of Debt AdjustmentToPrepaidExpensesAndOtherAssetsForForfeitedDepositInSettlementOfDebt	139618	usd
CY2024Q1	BGXX	Adjustment To Construction In Progress For Return Of Equipment In Settlement Of Debt AdjustmentToConstructionInProgressForReturnOfEquipmentInSettlementOfDebt	425085	usd
CY2024Q1	BGXX	Adjustment To Other Investment Held At Fair Value For Return Of Shares In Settlement Of Debt AdjustmentToOtherInvestmentHeldAtFairValueForReturnOfSharesInSettlementOfDebt	645638	usd
CY2024Q1	BGXX	Settlement Of Accounts Payable In Exchange For Other Investment Held At Fair Value SettlementOfAccountsPayableInExchangeForOtherInvestmentHeldAtFairValue	-568930	usd
CY2024Q1	BGXX	Settlement Of Due To Others In Exchange For Other Investment Held At Fair Value SettlementOfDueToOthersInExchangeForOtherInvestmentHeldAtFairValue	-1650000	usd
CY2024Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-04-16
CY2024Q1	us-gaap	Revenues Revenues	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-949450	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2613265	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-58552	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	273391	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48152919	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47203469	usd
CY2024Q1	BGXX	Working Capital Deficit WorkingCapitalDeficit	4621021	usd
CY2023Q4	BGXX	Working Capital Deficit WorkingCapitalDeficit	5968030	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	110000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	15000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	14800000	usd
CY2023Q4	us-gaap	Investments Investments	726343	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	1860	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	11483	usd
CY2024Q1	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The amount recognized is the largest amount of tax benefit that is greater than 50% likely to be realized on examination.
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_z6maVCizxKp6" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zoxVA4K3u9q4">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities, and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to valuation allowance for deferred tax assets, valuation of warrants, stock options, and stock-based compensation, going concern assessment, and assignment of the useful lives of property, plant, and equipment. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BRIGHT GREEN CORPORATION </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Condensed Consolidated Financial Statements (Unaudited)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended March 31, 2024 and 2023</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in United States Dollars)</span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"> </div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <span style="text-decoration: underline">Summary of Significant Accounting Policies (continued)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	187821	usd
CY2024Q1	BGXX	Change In Fair Value Of Assets And Liabilities Net ChangeInFairValueOfAssetsAndLiabilitiesNet	80705	usd
CY2023Q4	us-gaap	Other Investment Not Readily Marketable Fair Value OtherInvestmentNotReadilyMarketableFairValue	726343	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2024Q1	us-gaap	Land Land	260000	usd
CY2023Q4	us-gaap	Land Land	260000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10266838	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10635866	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19499379	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19868407	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3605020	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3460992	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15894359	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16407415	usd
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	6450	usd
CY2023Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6450	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	150000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	10000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	14800000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190166318	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190166318	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184758818	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184758818	shares
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	880000	usd
CY2023Q1	us-gaap	Transfer To Investments TransferToInvestments	880000	usd
CY2024Q1	BGXX	Warrant Redeemed Or Called During Period Shares WarrantRedeemedOrCalledDuringPeriodShares	200000	shares
CY2024Q1	BGXX	Warrant Redeemed Or Called During Period Value WarrantRedeemedOrCalledDuringPeriodValue	210000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	800000	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	55617	usd
CY2022Q3	us-gaap	Escrow Deposit EscrowDeposit	7650	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	316850	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	78400	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7399000	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6901000	usd
CY2022Q3	BGXX	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	498000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2425000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.3353
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y10M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	625000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.3353
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1800000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.3353
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y7M6D
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	600000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	0	shares
CY2024Q1	us-gaap	Interest Expense InterestExpense	15000	usd
CY2024Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	166235	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_804_eus-gaap--LossContingencyDisclosures_z8eEKZEL6EW7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_821_zqJ7o2ph6L6a">Contingencies</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company is routinely defendants in, or parties to a number of pending and threatened legal actions including actions brought on behalf of various classes of claimants. In view of the inherent difficulty of predicting the outcome of such matters, the Company cannot state what the eventual outcome of such matters will be. Legal provisions are established when it becomes probable that the Company will incur an expense related to a legal action and the amount can be reliably estimated. Such provisions are recorded at the best estimate of the amount required to settle any obligation related to these legal actions as at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation. Management and internal and external experts are involved in estimating any amounts that may be required. The actual costs of resolving these claims may vary significantly from the amount of the legal provisions. The Company’s estimate involves significant judgement, given the varying stages of the proceedings, the fact that the Company’s liability, if any, has yet to be determined and the fact that the underlying matters will change from time to time. Other than as set forth below, the Company is not presently a party to any litigation. The Company is not able to make a reliable assessment of the potential losses as these matters are at an early stage, accordingly, no amounts have been accrued in the condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BRIGHT GREEN CORPORATION </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Condensed Consolidated Financial Statements (Unaudited)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended March 31, 2024 and 2023</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in United States Dollars)</span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"> </div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <span style="text-decoration: underline">Contingencies (continued)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. John Fikany, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company filed a complaint for declaratory judgment against a consultant of the <span id="xdx_909_eus-gaap--LossContingencyActionsTakenByDefendant_c20240101__20240331__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zYWOPXb2h0yi">Bright Green Group of Companies, an entity unrelated to the Company, to determine if defendant is entitled to 5,000,000 shares of the Company’s common stock, based on a failure to fulfill agreed upon conditions precedent to earning such shares from the Company.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defendant counterclaimed and filed a third-party claim against a director of the Company, and her spouse, for claims including wrongful termination and breach of contract. The Company denies defendants allegations and have set forth arguments refuting defendant’s counterclaims and third-party claims. The case has proceeded to trial and a decision is expected in the second half of 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. Jerry Capussi, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company and defendant, a former consultant of Sunnyland Farms Inc., an entity unrelated to the Company, have each filed claims for declaratory judgment seeking to determine by court order whether defendant is entitled to <span id="xdx_901_eus-gaap--LossContingencyActionsTakenByDefendant_c20240101__20240331_zhHJpzsU7sRe" title="Contingency, taken by defendant description">(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of Bright Green Grow Innovations, LLC, a predecessor company of Bright Green Corporation.</span> The lawsuit is in early discovery stages, and the Company is preparing arguments for a summary judgment motion. There are no claims for specific monetary liability against either party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Loss Contingency Actions Taken By Defendant LossContingencyActionsTakenByDefendant	(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of Bright Green Grow Innovations, LLC, a predecessor company of Bright Green Corporation.

Files In Submission

Name	View Source	Status
0001493152-24-020671-index-headers.html	Edgar Link	pending
0001493152-24-020671-index.html	Edgar Link	pending
0001493152-24-020671.txt	Edgar Link	pending
0001493152-24-020671-xbrl.zip	Edgar Link	pending
bgxx-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
bgxx-20240331_cal.xml	Edgar Link	unprocessable
bgxx-20240331_def.xml	Edgar Link	unprocessable
bgxx-20240331_lab.xml	Edgar Link	unprocessable
bgxx-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BGXX
Bright Green Corp Stock $bgxx

2024 Q1 Form 10-Q Financial Statement

#000149315224020671 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX Bright Green Corp Stock $bgxx

2024 Q1 Form 10-Q Financial Statement

#000149315224020671 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX
Bright Green Corp Stock $bgxx